American Vanguard AI Stock Analysis
Want to see AVD full AI Analyst Report?
American Vanguard (AVD) AI Stock Analysis
American Vanguard
(NYSE:AVD)
The score is held down primarily by weak financial performance (net losses and negative operating/free cash flow) and clearly bearish technical signals (price below key moving averages with negative MACD). Valuation is difficult to justify positively due to a negative P/E, while the latest earnings call provides only partial offset: Q4 improvement initiatives and liquidity progress were tempered by lowered full-year guidance and leverage near covenant limits.
American Vanguard (AVD) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $25.89M
- Dividend Yield
- ―
- Average Volume (3M)
- 423.16K
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 1.54
- Revenue Growth
- -5.79%
- EPS Growth
- 46.69%
- Country
- US
- Employees
- 739
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Agricultural Inputs
American Vanguard Business Overview & Revenue Model
Company Description
American Vanguard Corporation, through its various subsidiaries, develops, manufactures, and markets a diverse portfolio of specialized chemicals for agricultural, commercial, and consumer applications across the United States and internationally. Th...
How the Company Makes Money
American Vanguard primarily makes money by selling pest-control and crop protection chemicals and related solutions, with revenue recognized from product shipments to customers through multiple go-to-market channels. Key revenue streams include: (1)...
American Vanguard Earnings Call Summary
The call presented a mixed outlook. Management highlighted improved customer prepayments, liquidity, cost actions, new product and portfolio initiatives, and expectations for stronger fourth-quarter results. However, third-quarter revenue and EBITDA declined, gross margins contracted, international markets remained weak, transportation costs increased sharply, leverage stayed close to the covenant maximum, and full-year revenue and adjusted EBITDA guidance were reduced. The positive initiatives and fourth-quarter expectations were balanced by significant current operating and market challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
American Vanguard now expects full year 2026 revenue to be in the range of $500 million to $530 million and adjusted EBITDA to come in the $36 million to $40 million range; for the fourth quarter, it projects net sales of approximately $166 million, up 10% versus the year ago period, and adjusted EBITDA of $21 million, up roughly 25% versus last year's fourth quarter, while anticipating fourth quarter prepayment and early pay collections of $45 million and net working capital to be a positive contributor to liquidity. The Syngenta portfolio and Sipcam Agro distribution agreement are projected to add a total of $15 million to $20 million in annualized revenue over the next 12 months, the company’s goal remains 50 new product launches, driving $100 million in annualized revenue by 2030, and it expects to reach an annualized run rate of more than $600 million in sales by the back half of 2028, approximately 20% above our 2025 level.
American Vanguard Financial Statement Overview
Summary
Operating results and cash generation are the key weaknesses: TTM revenue is down (-2.1%) with a sizable net loss (~-12% net margin) and negative operating/free cash flow. The balance sheet is more supportive (low TTM debt-to-equity ~0.13x), but recent leverage history was elevated and returns are negative (TTM ROE ~-27.8%), keeping the overall financial profile pressured despite some improvement from 2024.
Income Statement
28NegativeBalance Sheet
54NeutralCash Flow
24Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 499.39M | 515.11M | 547.31M | 579.37M | 609.62M | 557.68M |
| Gross Profit | 141.99M | 147.56M | 120.32M | 179.16M | 241.35M | 170.72M |
| EBITDA | -11.33M | -11.79M | -9.66M | 44.72M | 62.22M | 57.00M |
| Net Income | -59.89M | -49.88M | -126.34M | 7.52M | 27.40M | 18.59M |
Balance Sheet | ||||||
| Total Assets | 663.41M | 596.54M | 636.72M | 767.55M | 726.31M | 694.16M |
| Cash, Cash Equivalents and Short-Term Investments | 83.91M | 12.43M | 12.51M | 11.42M | 20.33M | 16.29M |
| Total Debt | 284.57M | 191.39M | 167.81M | 162.09M | 76.25M | 78.08M |
| Total Liabilities | 500.29M | 404.14M | 403.61M | 397.54M | 356.33M | 321.42M |
| Stockholders Equity | 163.12M | 192.40M | 233.11M | 370.01M | 369.98M | 372.74M |
Cash Flow | ||||||
| Free Cash Flow | -12.62M | -25.27M | -3.77M | -70.81M | 42.55M | 76.32M |
| Operating Cash Flow | -6.39M | -21.19M | 3.92M | -58.75M | 57.10M | 86.36M |
| Investing Cash Flow | -11.38M | -3.61M | -6.62M | -17.02M | -14.47M | -20.04M |
| Financing Cash Flow | 85.31M | 23.70M | 4.54M | 66.74M | -38.26M | -65.87M |
American Vanguard Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVD, the sentiment is Negative. The current price of 0.88 is below the 20-day moving average (MA) of 1.00, below the 50-day MA of 1.52, and below the 200-day MA of 2.68, indicating a bearish trend. The MACD of -0.18 indicates Negative momentum. The RSI at 27.36 is Positive, neither overbought nor oversold. The STOCH value of 26.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVD.
American Vanguard Risk Analysis
American Vanguard disclosed 28 risk factors in its most recent earnings report. American Vanguard reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
3 New RisksAmerican Vanguard Peers Comparison
Overall Rating
IPI65Neutral
UAN65Neutral
BHST43Neutral
AVD42Neutral
BIOX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | $439.82M | 17.91 | 4.81% | ― | 5.04% | ― | |
| 65Neutral | $1.19B | 11.15 | 35.58% | 12.85% | 7.31% | -16.36% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 43Neutral | $34.12M | -2.74 | -55.88% | ― | 4.76% | 23.09% | |
| 42Neutral | $25.89M | -0.42 | -32.98% | ― | -5.79% | 46.69% | |
| 38Underperform | $13.40M | -0.06 | -216.09% | ― | -26.10% | 14.85% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AVD | American Vanguard Corporation | 0.88 | -3.92 | -81.75% | |
| UAN | CVR Partners LP | 112.60 | 23.10 | 25.80% | |
| IPI | Intrepid Potash Inc | 32.91 | 7.95 | 31.85% | |
| BHST | Bioharvest Sciences, Inc. | 1.50 | -5.16 | -77.40% | |
| BIOX | Bioceres Crop Solutions | 0.21 | -1.33 | -86.41% |
American Vanguard Corporate Events
American Vanguard Reports Third-Quarter 2026 Financial Results
NegativeOn November 9, 2026, American Vanguard reported unaudited third-quarter and nine-month results ended September 30, 2026. Third-quarter net sales fell to $108 million from $119 million, gross margin to 24% from 29%, operating loss widened to $8.0 mill...
American Vanguard appoints new chief financial officer
PositiveOn October 1, 2026, American Vanguard’s board completed a planned leadership transition in its finance organization, appointing 43-year-old Matthew Horwath as Chief Financial Officer and moving long-serving CFO David Johnson to the role of Chief Acco...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
